1Molecular and Cell Biology Program, Ohio University, 2Department of Biomedical Sciences, College of Osteopathic Medicine, Ohio University, 3Department of Biomedical Engineering, Russ College of Engineering and Technology, Ohio University
Muccioli, M., Pate, M., Omosebi, O., Benencia, F. Generation and Labeling of Murine Bone Marrow-derived Dendritic Cells with Qdot Nanocrystals for Tracking Studies. J. Vis. Exp. (52), e2785, doi:10.3791/2785 (2011).
Dendritic cells (DCs) are professional antigen presenting cells (APCs) found in peripheral tissues and in immunological organs such as thymus, bone marrow, spleen, lymph nodes and Peyer's patches 1-3. DCs present in peripheral tissues sample the organism for the presence of antigens, which they take up, process and present in their surface in the context of major histocompatibility molecules (MHC). Then, antigen-loaded DCs migrate to immunological organs where they present the processed antigen to T lymphocytes triggering specific immune responses. One way to evaluate the migratory capabilities of DCs is to label them with fluorescent dyes 4.
Herewith we demonstrate the use of Qdot fluorescent nanocrystals to label murine bone marrow-derived DC. The advantage of this labeling is that Qdot nanocrystals possess stable and long lasting fluorescence that make them ideal for detecting labeled cells in recovered tissues. To accomplish this, first cells will be recovered from murine bone marrows and cultured for 8 days in the presence of granulocyte macrophage-colony stimulating factor in order to induce DC differentiation. These cells will be then labeled with fluorescent Qdots by short in vitro incubation. Stained cells can be visualized with a fluorescent microscopy. Cells can be injected into experimental animals at this point or can be into mature cells upon in vitro incubation with inflammatory stimuli. In our hands, DC maturation did not determine loss of fluorescent signal nor does Qdot staining affect the biological properties of DCs. Upon injection, these cells can be identified in immune organs by fluorescent microscopy following typical dissection and fixation procedures.
1. Dissection of mouse femurs and tibiae and culture of bone marrow cells
2. Collection and labeling of DCs
3. Evaluation of labeled DC
4. Representative Results:
Herewith we described how to prepare murine bone marrow-derived DCs and how labeled them with fluorescent Qdots. Fig. 1 summarizes the procedure to obtain the cell, while Fig. 2 depicts the procedure to label them with Qdots. As shown in Fig. 3, almost all the cells are labeled by this procedure, and this is not affected by DC maturation with inflammatory factors (Fig. 4). Fig. 5 shows that Qdot-stained DCs (Fig.5a) behave similar to non-stained cells when treated with an inflammatory cocktail. Both cell preparations similarly upregulate expression of costimulatory molecules (Fig. 5b); and produce similar amounts of IL-6 (Fig. 5c) and nitric oxide (Fig. 5d) upon maturation stimuli. This agrees with previous published data indicating that Qdot staining does not affect the capability of DC to turn into mature cells capable of eliciting immune responses . These cells can then be used for injecting experimental animals. As shown in Fig. 6, 2 days after intravenous injection of labeled DCs into mice, we were able to detect Qdot-stained cells in the spleen. This is also in agreement with previous published data showing the use of Qdot nanocrystals to evaluate migration of DC in vivo  by non-invasive imaging and flow cytometry.
Figure 1. Flow chart of DC generation from bone marrow. Herewith we depict the process to obtain bone marrow-derived DC. Both tibias and femurs are dissected and clean from surrounding tissue. Bone tips are preserved and the interior of the bones are flushed with medium. After eliminating red blood cells, bone marrow cells are cultured for 8 days in the presence of GM-CSF to differentiate them into DCs.
Figure 2. Flow chart of the labeling procedure. Equal aliquots of Qtracker Cell Labeling Kit components A and B are mixed in an eppendorf tube. Dendritic cells are collected from 8-day bone marrow cultures with GM-CSF and mixed with the labeling dye for 60 min at 37C. Then cells are washed in media to eliminate excess labeling particles.
Figure 3. Fluorescent microphotography of DCs immediately after labeling. A drop of labeled cells was deposited on a glass slide and covered by a coverslip. Then, samples were evaluated in a fluorescence microscope and images were acquired through a Micropublisher 5.0 Digital CCD Color Camera (Qimaging, Surrey, BC Canada).
Figure 4. Fluorescent microphotography of DCs after 48 h maturation in vitro. Labeled DCs were cultured for 48 h with LPS (100 ng/ml) and TNF-α (20 ng/ml) on glass slides on a CO2 incubator (37°C, 5% CO2). Then, samples were washed with PBS (5 min, 2X), fixed with acetone (15 min, 4°C) and counterstained with DAPI. Cells were evaluated in a fluorescent microscope as above.
Figure 5. Biological activity of Qdot stained mature DCs. Labeled DCs matured in vitro as above were analyzed by flow cytometry (A) and (B). (A) Qdot-stained cells give a strong signal in the FL3 (PercP) channel. Shaded histogram: unstained control. (B) Qdot-stained and unstained DCs were additionally stained with specific antibodies against maturation markers CD86 and CD40; and isotype controls. Cells were then analyzed in a FACSort flow cytometer (Becton Dickinson, San Jose, CA). Additionally, IL-6 (C) and nitric oxide (NO) were determined in supernatants of mature Qdot-stained DCs and controls. Levels of IL-6 and nitric oxide were determined by means of ELISA analysis and Griess assay as we have previously described 7, 8. All the data showed in this figure is representative of two or three independent experiments showing similar results. Data was analyzed by ANOVA by using the GraphPad software.
Figure 6. Detection of labeled DCs in dissected tissues. Labeled mature DCs (1x106 cells) were intravenously injected into C57BL/6 mice. (A) Two days later mice were sacrificed and spleens collected, snap frozen, embedded in OCT, and 8 μM sections prepared using a cryostat. Then, samples were fixed with acetone (15 min, 4°C) and counterstained with DAPI. Cells were evaluated in a fluorescent microscope as above. Fig 6a: 40X magnification, Fig 6b: 100X magnification, Fig. 6C, 400X magnification.
Murine myeloid) DCs have been extensively used in order to determine the efficacy and improvement of DC-based vaccines; investigate DC:T cell interactions or DC development; and determine their role in various diseases 9-11. Herewith we show how to generate DCs from precursors recovered from bone marrows of tibias and femurs. We recover the bones without cutting the tips, allowing us to sterilize them by submersion in ethanol 70%, thus reducing the probability of contamination. To differentiate DCs from bone marrow cells we only use GM-CSF as previously described 5. Although some protocols also use IL-4, it has been reported that this cytokine is not necessary when working with high levels of GM-CSF 12. Indeed, we have previously demonstrated that these DCs are able to induce immune responses 13. Also, care has to be taken to recover only loosely adherent cells from 8-day cultures by washing the Petri dishes with medium since attached cells show a more monocyte-like phenotype. Here we show the labeling of DCs with fluorescent Qdot particles. This labeling has some advantages respect to other methods. First, the Qdots particles are easily incorporated into the cells. Second, the fluorescent signal is very high and is not altered by DC maturation. Third, the fluorescence is not lost when cells or tissues are fixed with solvents such as acetone, contrary to what happens if GFP is used to tag DCs 14, giving more flexibility at the moment to choose staining protocols. Finally, the high fluorescent signal given by these particles allows visualization of the cells despite tissue auto-fluorescence. As previously described 6, Qdot staining did not affect the maturation capability of these cells. Herewith we show that Qdot-stained DCs behave in a similar way as non-stained DCs, upregulating costimulatory molecules, and producing IL-6 and nitric oxide in response to inflammatory stimuli. Although DCs are cells specialized in triggering immune responses, they have been shown to participate in pathological conditions such as cancer and atherosclerosis 4, 15, 16. They have been also claimed to participate in angiogenic process 17, 18, even suggested as structurally participating in the developing of new vessels 19, 20. Thus, methods that allow for DC tracking in vivo, and determining their geographical localization in different tissues 4, 21, 22 are very valuable.
No conflicts of interest declared.
This work supported in part by the NIH under Grant R15 CA137499-01 (F.B.) and a startup fund from Ohio University (F.B.).
|C57BL/6 mice||Jackson Laboratory||Females, 6-8 weeks old|
|Fetal bovine serum, qualified||Invitrogen||10437-028|
|ACK Lysing Buffer||Lonza Inc.||10-548E|
|Recombinant murine GM-CSF||PeproTech Inc||315-03|
|Qtracker 655 Cell Labeling Kit||Invitrogen||Q25021MP|
|Recombinant murine TNF alpha||PeproTech Inc||315-01A|
|CD86 antibody||BD Biosciences||553691|
|CD40 antibody||BD Biosciences||553791|
|Griess reagent system||Promega Corp.||G2930|
|IL-6 capture antibody||eBioscience||13-7061-81|
|IL-6 detection antibody||eBioscience||13-7062-81|